We are live on
!
Find out more
ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
274 hedge funds and large institutions have $3.85B invested in Intra-Cellular Therapies Inc. in 2022 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 103 increasing their positions, 86 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
23% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 35
20% more repeat investments, than reductions
Existing positions increased: 103 | Existing positions reduced: 86
13% more call options, than puts
Call options by funds: $21.3M | Put options by funds: $18.9M
3% more funds holding
Funds holding: 266 → 274 (+8)
16% less capital invested
Capital invested by funds: $4.57B → $3.85B (-$727M)
36% less funds holding in top 10
Funds holding in top 10: 11 → 7 (-4)
Holders
274
Holders Change
+8
Holders Change %
+3.01%
% of All Funds
4.72%
Holding in Top 10
7
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-36.36%
% of All Funds
0.12%
New
43
Increased
103
Reduced
86
Closed
35
Calls
$21.3M
Puts
$18.9M
Net Calls
+$2.43M
Net Calls Change
-$6.17M
Top Buyers
| 1 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$46.1M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$45.3M |
| 3 |
Millennium Management
New York
|
+$42M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$36.3M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$34.3M |
